Malignant hyperthermia is a rare complication of the use of the following anaesthetic:
**Core Concept**
Malignant hyperthermia is a life-threatening medical emergency that occurs in response to certain volatile anesthetics and depolarizing muscle relaxants, leading to an uncontrolled rise in body temperature and metabolic rate. This condition is characterized by muscle rigidity, tachycardia, and a significant increase in end-tidal CO2, often in the setting of a general anesthetic.
**Why the Correct Answer is Right**
The condition is caused by an abnormality in the ryanodine receptor type 1 (RyR1) gene, which codes for a calcium channel in the sarcoplasmic reticulum. When a depolarizing muscle relaxant like succinylcholine or a volatile anesthetic like halothane is administered, it triggers a massive release of calcium ions from the sarcoplasmic reticulum, leading to muscle rigidity and hypermetabolism. This results in a significant increase in oxygen consumption, lactic acid production, and a marked elevation in body temperature.
**Why Each Wrong Option is Incorrect**
* **Option A:** While barbiturates can have various side effects, they are not typically associated with malignant hyperthermia.
* **Option B:** Opioids are generally not linked to malignant hyperthermia, although they can cause respiratory depression and other adverse effects.
* **Option C:** Benzodiazepines are not typically associated with malignant hyperthermia and are often used as part of the treatment protocol to manage seizures and agitation.
**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia is a true medical emergency that requires immediate recognition and treatment, including the administration of dantrolene, which blocks calcium release from the sarcoplasmic reticulum and helps to control the body temperature.
**Correct Answer: D. Halothane**